P-21 Peptide

Potential Benefits of P-21 Peptide

• Exhibits neuroregenerative potential, possibly mitigating synaptic loss associated with neurodegenerative conditions.
• Demonstrates affinity for neuronal receptors in {name} studies, promoting neuroplasticity, essential for memory formation and cognitive flexibility.
• Modulates neurotrophic factors, thereby potentially enhancing neuronal survival and facilitating repair mechanisms.
• Might offer protective effects against amyloid-beta toxicity, which is implicated in Alzheimer’s disease pathology.
• Preclinical studies indicate improved cognitive performance in animal models, suggesting translational prospects for human therapies.
• May serve to complement existing Alzheimer’s treatments, potentially leading to more holistic and effective management protocols.
• Current {name} research is investigating P-21’s ability to cross the blood-brain barrier efficiently, a crucial factor for therapeutic viability.

References

[1] https://pubmed.ncbi.nlm.nih.gov/16415866/

[2] https://www.researchgate.net/ publication/376555308

[3] https://pubmed.ncbi.nlm.nih.gov/25174326/

[4] https://www.sciencedirect.com/ science/article/pii/ S001457931000520X

ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.

DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our Direct Peptides website: https://monaco.direct-peptides.com is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.